Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bupivacaine 50mg/Adrenaline (base) 50microg/10ml inj amp
1502010C0AAAJAJ
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,997 |
|
Tetracaine 4% gel
1502010A0AAAAAA
|
Tetracaine | Tetracaine | Anaesthesia | 1,909 |
|
Lidocaine 400mg/Adrenaline (base) 100microg/20ml inj vials
1502010J0AAA3A3
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 1,885 |
|
Bonjela Junior gel
1502010J0BVAAEQ
|
Bonjela | Lidocaine hydrochloride | Anaesthesia | 1,869 |
|
Bupivacaine 25mg/10ml (0.25%) inj ampoules
1502010C0AAABAB
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,799 |
|
Lidocaine 10% spray sugar free
1502010I0AAACAC
|
Lidocaine (Local Anaesthesia) | Lidocaine | Anaesthesia | 1,689 |
|
Alfentanil 1mg/2ml solution for injection ampoules
1501043A0AAABAB
|
Alfentanil hydrochloride | Alfentanil hydrochloride | Anaesthesia | 1,563 |
|
Midazolam 5mg/5ml solution for injection ampoules
1501041T0AAASAS
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | 1,554 |
|
Nulbia 5% cream
1502010J0BXAABY
|
Nulbia | Lidocaine hydrochloride | Anaesthesia | 1,460 |
|
Bupivacaine 25mg/Adrenaline (base) 50microg/10ml inj amp
1502010C0AAAIAI
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,410 |
|
Lidocaine 44mg/Adrenaline (base) 27.5microg/2.2ml inj cart
1502010J0AACQCQ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 1,301 |
|
Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules
1502010C0AAADAD
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 862 |
|
Scandonest plain 3% solution for injection 2.2ml cartridges
1502010ABBBABAB
|
Scandonest | Mepivacaine hydrochloride | Anaesthesia | 742 |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules
1502010J0AACJCJ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 718 |
|
LMX 4 cream
1502010I0BGAAAK
|
LMX | Lidocaine | Anaesthesia | 588 |
|
Lidocaine 200mg/20ml (1%) solution for injection vials
1502010J0AAADAD
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 560 |
|
Midazolam 2mg/2ml solution for injection ampoules
1501041T0AAATAT
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | 556 |
|
Ametop 4% gel dispensing pack
1502010A0BBABAB
|
Ametop | Tetracaine | Anaesthesia | 534 |
|
Hyoscine hydrobromide 600micrograms/1ml inj ampoules
1501030H0AAABAB
|
Hyoscine hydrob (parent) | Hyoscine hydrobromide | Anaesthesia | 521 |
|
Marcain 0.25% inj 10ml Polyamp Steripack ampoules
1502010C0BBAIAB
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | 521 |
|
Midazolam 10mg/5ml solution for injection ampoules
1501041T0AAABAB
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | 434 |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules
1502010J0AACUCU
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 427 |
|
Lidocaine hydrochlor 0.5%/Cetylpyr chlor 0.025% gel SF
1502010J0AAEQEQ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 374 |
|
Marcain 0.5% inj 10ml Polyamp Steripack ampoules
1502010C0BBAJAD
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | 367 |
|
Fentanyl 100micrograms/2ml solution for injection ampoules
1501043F0AAAAAA
|
Fentanyl citrate | Fentanyl citrate | Anaesthesia | 346 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.